|
E-mail this page to a friend!
Senior Citizen Politics
Senior Citizen Hot Button Issue - Drug Importation -
Takes Center Stage in Senate
Senate bill sponsored by North Dakota Democrat Byron
Dorgan and Maine Republican Olympia Snowe, draws fire from drugmakers
Dec. 10, 2009 - Debate on a proposal that
would make it easier to bring prescription drugs into the country from
abroad is taking center stage on the Senate floor as part of the health
care reform debate.
The Associated Press: "A bipartisan group of lawmakers hopes to
finally win a long struggle to ease curbs against importing low-cost
prescription drugs but will have to overcome the Obama administration
and the pharmaceutical industry to do so."
The amendment would "allow U.S. pharmacies and drug
wholesalers to import Food and Drug Administration-approved drugs from
Canada, Europe and a few other countries. People on both sides of the
issue say it will be tough for supporters to get the 60 votes they'll
need to win" (Fram, 12/10).
The Seattle Times/The Associated Press: "Some import supporters
question whether the administration is acting to keep the powerful
pharmaceutical industry's support for [President Barack] Obama's effort
to overhaul the nation's health-care system. An administration official
denied that. ... Even before Dorgan introduced it Tuesday night, the
Food and Drug Administration (FDA) sent senators a letter saying the
plan would be 'logistically challenging' to implement and raises
'significant safety concerns.' ...
Dorgan said he was surprised by the letter because
Obama co-sponsored Dorgan's proposal in 2007 as a freshman Democratic
senator from Illinois. In addition, Dorgan noted, White House Chief of
Staff Rahm Emanuel sponsored another version of the bill that same year
as a Democratic House member from Illinois" (Fram, 12/10).
The Wall Street Journal: "In a letter to Republican Sen. Sam
Brownback of Kansas, FDA Commissioner Margaret Hamburg also said
overseeing importation would be 'resource intensive.' The letter was a
response to a request by Sen. Brownback, who in the past has opposed
reimportation of drugs." Dorgan responded by calling the FDA letter
"completely bogus" (Mundy, 12/9).
Bloomberg reports that drugmakers are speaking out against a
proposal to allow reimportation of cheaper prescription drugs from
Canada. "The plan, from lawmakers led by (senators) North Dakota
Democrat Byron Dorgan and Maine Republican Olympia Snowe, drew fire from
drugmakers such as Indianapolis-based Eli Lilly & Co."
"'It would be a huge mistake for Congress to pursue
policies that could expose Americans to counterfeit and substandard drug
products,' said Ken Johnson, senior vice president of the Pharmaceutical
Research and Manufacturers of America, the Washington industry
association" (Gaouette and Jensen, 12/10).
CQ HealthBeat also reports on the FDA letter: "It was unclear when
the Senate might vote on the amendment offered by Byron L. Dorgan, D-N.D.
... John McCain, R-Ariz., said the deal with the pharmaceutical industry
was the real reason behind the FDA letter. He mocked the agency's
reasoning in the letter. ... [Meanwhile], Hamburg ended the letter by
promising to work with senators to explore other options for drug
importation (Ethridge, 12/9).
See related news on Wednesday's Senate negotiations
and debate on drug re-importation at
Kaiser Health News.
NOTE: This is part of Kaiser
Health News' Daily Report - a summary of health policy coverage from
more than 300 news organizations. The full summary of the day's news can
be found
here and you can sign up for e-mail subscriptions to the Daily
Report
here. In addition, KHNs staff of reporters and correspondents file
original stories each day, which can be found on the
home page.
|
This
information was reprinted from
kaiserhealthnews.org with permission from the Henry J.
Kaiser Family Foundation. You can view the entire Kaiser
Daily Health Policy Report, search the archives and sign up
for email delivery. © Henry J. Kaiser Family Foundation. All
rights reserved. |
Click to More Senior News on the
Front Page
Copyright: SeniorJournal.com |